Letter to the Editor: GLP-1 receptor expression within the human heart
Goh, C., Finkel, M., Christos, P
As liraglutide and semaglutide induced stronger HbA1c reductions versus placebo then lixisenatide, it was important that the authors showed in reply to a letter to the editor that the anti-albuminuric effects were independent of glucose-lowering in post-hoc analyses
But in many ways, the personalized dosages on [ augment ] what is commercially available
Additional information on the generation of gFA maps is provided in the Supplementary Data
GLP1 receptor agonists offer a therapeutic breakthrough by mimicking the glucagonlike peptide1 hormone, boosting insulin secretion and suppressing glucagon release, thereby enhancing glycemic control